Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Front Immunol ; 13: 902515, 2022.
Article in English | MEDLINE | ID: mdl-35874682

ABSTRACT

H9N2 and H3N2 are the two most important subtypes of low pathogenic avian influenza viruses (LPAIV) because of their ongoing threat to the global poultry industry and public health. Although commercially available inactivated H9N2 vaccines are widely used in the affected countries, endemic H9N2 avian influenza remains uncontrolled. In addition, there is no available avian H3N2 vaccine. Influenza virus-like particles (VLPs) are one of the most promising vaccine alternatives to traditional egg-based vaccines. In this study, to increase the immunogenic content of VLPs to reduce production costs, we developed chimeric bivalent VLPs (cbVLPs) co-displaying hemagglutinin (HA) and neuraminidase (NA) of H9N2 and H3N2 viruses with the Gag protein of bovine immunodeficiency virus (BIV) as the inner core using the Bac-to-Bac baculovirus expression system. The results showed that a single immunization of chickens with 40µg/0.3mL cbVLPs elicited an effective immune response and provided complete protection against H9N2 and H3N2 viruses. More importantly, cbVLPs with accompanying serological assays can successfully accomplish the strategy of differentiating infected animals from vaccinated animals (DIVA), making virus surveillance easier. Therefore, this cbVLP vaccine candidate would be a promising alternative to conventional vaccines, showing great potential for commercial development.


Subject(s)
Influenza A Virus, H9N2 Subtype , Influenza in Birds , Vaccines, Virus-Like Particle , Animals , Antibodies, Viral , Cattle , Chickens , Influenza A Virus, H3N2 Subtype , Vaccination/veterinary , Vaccines, Inactivated
2.
Chinese Journal of School Health ; (12): 733-736, 2021.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-877140

ABSTRACT

Objective@#To explore body mass index (BMI) changes among children and adolescents in Suzhou before and after COVID-19 outbreak, and to provide a reference for improving physical health of children and adolescents.@*Methods@#A total of 569 children and adolescents who had complete BMI information in 2019 were enrolled through stratified cluster sampling from June to July, 2020. Questionnaire survey was conducted, and height and weight were measured to calculate BMI and BMI Z scores.@*Results@#After the epidemic, overweight/obesity rate were 32.0%, compared to 31.6% before the epidemic(χ 2=0.07, P>0.05). Difference of BMI Z scores before (0.37±1.28) and after (0.38±1.27) the epidemic did not show statistically significant (t=-0.28, P>0.05), No significant changes in BMI Z score were found before and affer COVID-19 outbreak similar results were observed (P>0.05), BMI Z scores after the epidemic (0.45±1.32) was higher than it before the epidemic (0.37±1.35) among primary school group (t=2.57, P=0.01), while BMI Z scores after the epidemic (0.27±1.17) was lower than it before the epidemic (0.39±1.18) among middle school group (t=-4.29, P<0.01). Proportion of sweet food consumption and outdoor activities was statistically different before and after the epidemic(P>0.05), proportion of sugar-sweetened beverages consumption and fried food intake were statistically different before and after the epidemic (P<0.05), sleep time after the epidemic (8.52±1.83)h was higher than it before the epidemic (8.05±1.70)h (t=4.96, P<0.05).@*Conclusion@#Before and after COVID-19 outbreak, BMI and overweight/obesity rates are significantly different among children and adolescents in Suzhou, and there is a slight difference in different studying phases.

3.
Chin Med J (Engl) ; 133(12): 1404-1408, 2020 Jun 20.
Article in English | MEDLINE | ID: mdl-32472784

ABSTRACT

BACKGROUND: It is a challenge to characterize the consciousness level of patients with severe disturbance of consciousness and predict their prognosis effectively for Chinese doctors. We aimed to investigate the psychometric property and the diagnostic practicality of severe disturbance of consciousness by Chinese Nanjing persistent vegetative state scale (CNPVSS) which was first set up in 1996 and modified in 2001 and 2011. METHODS: The concurrent validity, inter-rater consistency and diagnostic accuracy of CNPVSS and Chinese version of coma recovery scale-revised (CRS-R) were investigated by assessment of 380 patients with severe disorders of consciousness. RESULTS: Total scores of the CNPVSS were correlated significantly with that of the CRS-R, indicating acceptable concurrent validity. Sub-scale analysis showed moderate to high inter-rater reliability and test-retest reliability. CNPVSS was superior to CRS-R on the diagnosis sensitivity. The CNPVSS was able to distinguish 65 patients in emergence from minimal consciousness state who were misclassified as in minimal consciousness state (MCS) by the CRS-R, and it could also distinguish two patients in MCS who were misclassified as in vegetative state by the CRS-R. CONCLUSION: The CNPVSS is an appropriate measurement and is sensitive to distinguish the MCS patients from the VS patients.


Subject(s)
Coma , Persistent Vegetative State , China , Humans , Persistent Vegetative State/diagnosis , Recovery of Function , Reproducibility of Results
4.
Appl Opt ; 58(14): 3892-3901, 2019 May 10.
Article in English | MEDLINE | ID: mdl-31158204

ABSTRACT

In this paper, 3-D, steady-state, analytical thermal models of high-power single-emitter semiconductor lasers (SEs) and laser diode arrays (LDAs) are derived, considering the heat conduction in multi-layered laser structures. Heat flow in the laser chips for an epi-down bonded SE and LDA is described using this model, and it is observed that the laser chips contribute to 8% and 6% of total heat dissipation for the SE and LDA, respectively. The submount size requirement for this model is discussed by revealing the heat flow in the submount. Through finite element simulations, the solution accuracy for the lasers with non-ideal submounts is confirmed. Finally, the performance of our proposed analytical models is verified by finite element simulations and experimental measurements based on the wavelength shift method.

5.
Brain Behav ; 9(5): e01279, 2019 05.
Article in English | MEDLINE | ID: mdl-30950244

ABSTRACT

OBJECTIVES: Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure of unknown etiology and venous sinus stenting may be an optional treatment. We aimed to evaluate the effects of venous sinus stenting on visual function, intracranial pressure, and trans-stenotic pressure gradient of the patients with IIH and to determine effects of baseline BMI or weight changes on subjective vision outcome and intracranial pressure. METHODS: From July 2009 to Aug 2016, 88 eligible patients with IIH and venous sinus stenosis who underwent stenting were retrospectively studied. RESULTS: In this study, 67 women and 21 men were included with an average age of 39.01 (18-60) years. The average BMI was 26.75 kg/m2 . Here, 66 (75.9%) patients had papilledema, 39 had impaired vision before stenting; 57 patients were followed-up, 48 (84.2%) showed significant subjective improvement or recovery in visual acuity, 4 (7.0%) patients reported no significant change in visual functions, and 5 (8.8%) suffered permanent vision loss. The cerebrospinal fluid opening pressure and trans-stenotic pressure gradient were significantly decreased postoperatively. Baseline BMI was associated with pre-and postoperative trans-stenotic pressure gradients, as well as changes in cerebrospinal fluid opening pressure. However, baseline BMI and body weight changes during follow-up were not necessarily associated with subjective visual outcomes after stenting. Stenting efficacy was limited in patients with severe preoperative optic symptoms. CONCLUSIONS: Venous sinus stenting represented an effective treatment for resolving visual dysfunction and intracranial pressure associated with venous sinus stenosis. BMI seemed to be associated with intracranial pressure but not subjective visual outcomes after stenting.


Subject(s)
Cranial Sinuses , Endovascular Procedures/methods , Prosthesis Implantation , Pseudotumor Cerebri/surgery , Stents , Vision Disorders , Adult , Body Mass Index , Cranial Sinuses/pathology , Cranial Sinuses/surgery , Female , Humans , Male , Prosthesis Implantation/instrumentation , Prosthesis Implantation/methods , Pseudotumor Cerebri/diagnosis , Pseudotumor Cerebri/physiopathology , Recovery of Function , Retrospective Studies , Treatment Outcome , Vision Disorders/diagnosis , Vision Disorders/etiology
6.
Appl Opt ; 58(8): 1966-1977, 2019 Mar 10.
Article in English | MEDLINE | ID: mdl-30874063

ABSTRACT

Numerical and analytical methods are employed to investigate the thermal and fluid flow performance of a microchannel heat sink for cooling a high-power diode laser bar. Heat transfer characteristics and pressure drop in the microchannel under different flow rates are studied. A thermal resistance network, which is proved to have less than 5.4% error, is proposed to characterize the resistance components for the microchannel heat sink. Both numerical modeling and thermal resistance network analysis are verified by experimental results based on the wavelength shift method. Two new heat sinks with more uniform temperature distribution for laser emitters compared with the existing design are presented, and their performance is validated by numerical modeling and spatially resolved spectrum measurements.

7.
Appl Opt ; 57(33): 9868-9876, 2018 Nov 20.
Article in English | MEDLINE | ID: mdl-30462024

ABSTRACT

An analytical, three-dimensional, steady-state thermal model of a high-power diode laser bar is presented in this paper. The heat spreading angle in a laser bar heat sink, subjected to several convective conditions on the bottom-side, was calculated with this model. Thermal design curves for the heat sink and submount are also presented. Special discussion is presented for two kinds of our conduction-cooled laser bars. Finite element simulation and experimental results based on the wavelength shift method are compared with this analytical solution. The familiar 45° angle in thermal design for a commercial hard solder conduction-cooled laser bar was found to lead to a 12% increase in thermal resistance relative to a free lateral diffusion heat sink.

8.
Sci Rep ; 7(1): 5087, 2017 07 11.
Article in English | MEDLINE | ID: mdl-28698595

ABSTRACT

Preeclampsia (PE) is a common pregnancy-related complication, and polymorphisms in angiotensinogen (AGT), angiotensin-converting enzyme (ACE), and angiotensin II type 1 receptor (AT1R) are believed to contribute to PE development. We implemented a hybrid study to investigate the influence of maternal and fetal ACE I/D, ACE G2350A, AGT M235T, AGT T174M, and AT1R A1166C polymorphisms on PE in Han Chinese women. Polymorphisms were genotyped in 1,488 subjects (256 patients experiencing PE, along with their fetuses and partners, and 360 normotensive controls with their fetuses). Transmission disequilibrium tests revealed that ACE I/D (P = 0.041), ACE G2350A (P = 0.035), and AT1R A1166C (P = 0.018) were associated with maternal PE. The log-linear analyses revealed that mothers whose offspring carried the MM genotype of AGT M235T had a higher risk of PE (OR = 1.54, P = 0.010), whereas mothers whose offspring carried the II genotype of ACE I/D or the GG genotype of ACE G2350A had a reduced risk (OR = 0.58, P = 0.039; OR = 0.47, P = 0.045, respectively). Our findings demonstrate that fetal ACE I/D, ACE G2350A, AGT M235T, and AT1R A1166C polymorphisms may play significant roles in PE development among pregnant Han Chinese women.


Subject(s)
Fetus/metabolism , Parents , Polymorphism, Genetic , Pre-Eclampsia/genetics , Renin-Angiotensin System/genetics , Adult , Case-Control Studies , Female , Gene-Environment Interaction , Genetic Association Studies , Genetic Loci , Genetic Predisposition to Disease , Humans , Likelihood Functions , Polymorphism, Single Nucleotide/genetics , Pregnancy , Risk Factors
9.
Medicine (Baltimore) ; 96(29): e7597, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28723803

ABSTRACT

RATIONALE: Leukoencephalopathy with calcifications and cysts (LCC) is an uncommon entity characterized by edematous leukoencephalopathy, cerebral calcifications, and parenchymal cysts. Due to its rarity, the clinical, radiological, and histopathological features have yet to be well elucidated. PATIENT CONCERNS: The first case is a 35-year-old female who was asymptomatic. A giant intracranial cyst was incidentally detected radiologically, and it was slowly growing in the recent 10 years. The second case is a 20-year-old female who presented with a 1-month history of headache. Brain computed tomography showed multiple asymmetric calcifications in the bilateral basal ganglia and white matter. Magnetic resonance imaging revealed a cyst in the right parietal lobe. DIAGNOSES: They were diagnosed with LCC. INTERVENTIONS AND OUTCOMES: The first patient underwent surgical resection of the intracranial cyst, and the second patient received a stereotactic biopsy. The patients performed well postoperatively. LESSONS: LCC can be found at any age. A young age seems to be associated with severer symptoms. The clinical manifestations can be variable and aggressive. The potential pathogenic basis still needs further research.


Subject(s)
Calcinosis/complications , Calcinosis/diagnostic imaging , Cysts/complications , Cysts/diagnostic imaging , Leukoencephalopathies/complications , Leukoencephalopathies/diagnostic imaging , Adult , Brain/diagnostic imaging , Brain/pathology , Brain/surgery , Calcinosis/pathology , Calcinosis/surgery , Cysts/pathology , Cysts/surgery , Diagnosis, Differential , Female , Humans , Leukoencephalopathies/pathology , Leukoencephalopathies/surgery , Young Adult
10.
Mol Cell Biochem ; 433(1-2): 103-112, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28378130

ABSTRACT

Endothelial dysfunction is one of the most important pathological events during the development of several diabetic complications including stroke. The aim of this work was to investigate the role of actin depolymerizing factor (ADF) in advanced glycation endproducts (AGEs)-induced impairment in mouse brain microvascular endothelial cells (MBMECs). Incubation of MBMECs with AGEs led to downregulation of expression of ADF, which was reversed by treatment with soluble receptor of AGEs or tempol (an antioxidant). Incubation of MBMECs with AGEs enhanced ratio of F/G-actin, increased endothelial permeability and reduced vasculogenic property, which was attenuated by overexpression of ADF. Furthermore, overexpression of ADF attenuated AGEs-induced downregulation of zonula occludens-1 and dephosphorylation of vascular endothelial growth factor receptor 2. Incubation of MBMECs with AGEs downregulated dimethylarginine dimethylaminohydrolase 2, enhanced formation of asymmetric dimethylarginine and reduced formation of nitric oxide, which was attenuated by overexpression of ADF. Incubation of MBMECs with AGEs induced activation of NF-κB, upregulated RAGE and enhanced formation of reactive oxygen species, which was attenuated by overexpression of ADF. Additionally, knockdown of ADF aggravated AGEs-induced impairment in endothelial permeability and vasculogenic property in MBMECs. In conclusion, AGEs treatment increased endothelial permeability and reduced vasculogenic property of MBMECs, at least in part, via downregulation of ADF.


Subject(s)
Brain/metabolism , Destrin/biosynthesis , Down-Regulation/drug effects , Endothelial Cells/metabolism , Glycation End Products, Advanced/pharmacology , Animals , Brain/blood supply , Brain/pathology , Cells, Cultured , Endothelial Cells/pathology , Glycation End Products, Advanced/metabolism , Mice , Receptor for Advanced Glycation End Products/metabolism
11.
Medicine (Baltimore) ; 96(6): e6084, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28178166

ABSTRACT

The aim of this study was to investigate whether there is a long-term improvement in headache of patients with unruptured intracranial aneurysms (UIAs) treated with intracranial endovascular procedures.Using a prospective design, consecutive patients with UIAs with neuroendovascular treatment from January 2014 to December 2014 were asked to participate. Headache outcomes were established before aneurysm treatment and for 6 months following treatment. Factors associated with different headache outcomes were investigated.Ultimately, 58 patients completed the 6-month follow-up. In total, 29 patients had preoperative headache. Six months after the intracranial endovascular procedure, 13 patients (44.8%) stated that their headaches were relieved after endovascular treatment; headache in 1 patient improved slightly, and 12 reported disappearance of headache and marked improvement. Overall, the mean headache scores of 29 patients improved on the self-reported Numeric Rating Scale (NRS) after endovascular treatment (6.00 vs. 2.30; P < 0.001). Patients with pretreatment tension-type headache, more severe headaches, stent-assisted coiling, and stent implantation of the aneurysm were the important disadvantage for patients in improvement of post-procedure headache.Treatment of UIAs resulted in relief of headaches in about half of patients who had headaches pre-operatively.


Subject(s)
Endovascular Procedures/methods , Headache/etiology , Headache/surgery , Intracranial Aneurysm/complications , Intracranial Aneurysm/surgery , Adult , Aged , China , Female , Humans , Male , Middle Aged , Prospective Studies
12.
Headache ; 57(3): 391-399, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27991669

ABSTRACT

BACKGROUND: Two editions of the International Classification of Headache Disorders (ICHD) diagnostic criteria for "Headache attributed to an intracranial endovascular procedure" have been published, in 2004 and 2013.1,2 Despite studies that have suggested that the former is not very practical, the ICHD-3 beta did not contain major changes. Moreover, so far no consensus exists regarding characteristics of headache after intracranial endovascular procedure. Thus, there is a need for sound suggestions to improve the ICHD-3 beta diagnostic criteria. METHODS: Using a prospective design, we identified consecutive patients with unruptured intracranial aneurysms (UIAs) with neuroendovascular treatment from January 2014 to December 2014. RESULTS: In total, 73 patients were enrolled, and 58 patients ultimately completed the 6-month follow-up. After the procedure, five of the 29 patients (17.2%) with pre-existing headache experienced marked worsening after the procedure, while seven of the 29 patients without prior headache developed new-onset headache post-procedurally. The headaches started within 24 hours, with a mean duration of 24-72 hours. The headaches were moderate to severe. The eligibility of these events to be considered headaches caused by neuroendovascular procedures according to the ICHD-3 beta diagnostic criteria for designation was far from ideal. CONCLUSIONS: Most cases of markedly worsening headaches and new-onset headaches started within 24 hours and persisted longer than that specified in the ICHD-3 beta diagnostic criteria. Moreover, considering that some items are not very practical, the ICHD-3 beta diagnostic criteria should be revised in the light of recent literature reports.


Subject(s)
Endovascular Procedures/adverse effects , Headache/etiology , Postoperative Complications/physiopathology , Adolescent , Adult , Age of Onset , Aged , Female , Humans , Intracranial Aneurysm/surgery , Male , Middle Aged , Postoperative Complications/diagnosis , Prospective Studies , Retrospective Studies , Young Adult
13.
J Huazhong Univ Sci Technolog Med Sci ; 35(6): 801-807, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26670428

ABSTRACT

The prevalence of hypertensive disorders in China was much higher than that in the United States. Considering the large population with wide geographic area of China, we aimed to add more information regarding the risk factors for hypertensive disorders of pregnancy. A case-control study was performed on 373 hypertensive cases and 507 normotensive controls. Participants were recruited from 2008 to 2014 in Yichang Maternal and Child Health Care Center in Hubei province and Anyang Maternal and Child Health Care Hospital in Henan province, China. Socio-demographic factors, family- related factors, pregnancy-associated factors, factors related to daily life behaviors and psychosocial factors were investigated with respect to hypertensive disorders in pregnancy through well-designed questionnaire. Chi-square test, t-test, univariate logistic regression analysis, and multivariate logistic regression analysis were used to find the possible risk factors behind hypertensive disorders in pregnancy. The results showed that family history of cardiovascular diseases (OR=6.18, 95% CI, 2.37 to 16.14), history of pregnancy-induced hypertension (OR=16.64, 95% CI, 5.74 to 48.22), low maternal educational level (OR=2.81, 95% CI, 1.30 to 6.04), and poor relationship with their parents-in-law (OR=3.44, 95% CI, 1.55 to 7.59) had statistically significant associations with hypertensive disorders in pregnancy through multivariate logistic regression analysis. Increased maternal age, increased pre-pregnancy body mass index, living in rural area, low paternal education level, family history of hypertension, passive smoking one year before and/or in pregnancy, and poor sleeping quality were significantly associated with hypertensive disorders in pregnancy from univariate logistic regression analysis while the associations became uncertain when they were entered for multivariate logistic regression analysis. It was concluded that family history of cardiovascular diseases, history of pregnancy-induced hypertension, low maternal educational level, and poor relationship with their parents-in-law were independent risk factors for hypertensive disorders among Chinese pregnant women.


Subject(s)
Hypertension/epidemiology , Pregnancy Complications, Cardiovascular/epidemiology , Adult , China/epidemiology , Female , Humans , Pregnancy , Risk Factors , Young Adult
14.
Cephalalgia ; 35(8): 644-51, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25286910

ABSTRACT

BACKGROUND: Although medication-overuse headache (MOH) is common in China, its clinical profile is not yet fully established. Meanwhile, ICHD-3 beta has been published, but its diagnostic criteria require further validation. METHODS: We retrospectively classified the clinical features of 240 consecutive patients with MOH (55 males, 185 females), whose demographic data, headache features, overused medications (type, quantity, frequency and duration of use), headache-attributed burden, and outcomes were reviewed. We then applied the criteria of the several versions of ICHD (II, IIR and 3-beta) to these patients. RESULTS: Compared with those with other headaches, patients with MOH were more likely to be less well educated (64.6% vs 42.0% for secondary school or lower, p < 0.0001), and on lower annual incomes (72.3% vs 56.0% for an income of Chinese yuan (CNY) 30,000 or less, p < 0.0001). Combination analgesics were the most commonly overused medications, and, caffeine (89.9%), aminopyrine (70.0%), phenacetin (53.9%) and phenobarbital (48.8%) were the most commonly used specific components of these. Only two patients (0.8%) had previously been given the diagnosis of MOH; accordingly, the median time to diagnosis after the estimated onset of the disorder was 4.0 years. The majority of patients (83.7%) improved with treatment. All 240 patients fulfilled the diagnostic criteria for MOH according to ICHD-3 beta; only 134 (55.8%) satisfied the diagnostic criteria for definite MOH according to ICHD-II, while 195 (81.2%) met those of ICHD-IIR. CONCLUSIONS: MOH in China is associated with lower educational level and annual income. MOH has rarely been diagnosed and correctly treated in China. ICHD-3 beta appears to be more appropriate for the diagnosis of MOH than previous versions.


Subject(s)
Headache Disorders, Secondary/diagnosis , Headache Disorders, Secondary/epidemiology , Adult , Aged , China/epidemiology , Female , Humans , International Classification of Diseases , Male , Middle Aged
15.
Asian Pac J Cancer Prev ; 15(18): 7611-5, 2014.
Article in English | MEDLINE | ID: mdl-25292036

ABSTRACT

AIMS: To prepare 5-fluorouracil (5-Fu) nanoparticles with higher encapsulation efficiency and drug loading, and then investigate interaction with the SGC-7901 gastric cancer cell line. MATERIALS AND METHODS: Prescription was optimized by orthogonal experiments, the encapsulation efficiency and loading capacity were tested by high- performance liquid chromatography, and inhibition of proliferation by 5-Fu nanoparticles and 5-Fu given to cells for 24, 48 and 72 hours was investigated by methyl thiazolyl tetrazolium assay (MTT). In addition, 5-Fu nanoparticles were labeled by fluorescein isothiocyanate (FITC), and absorption into cells was tested by flow cytometry. RESULTS: The optimal conditions for preparation were concentrations of 5-Fu of 5mg/ml, of CaCl2 of 60 mg/ml and of chitosan of 2 mg/ml. With a stirring speed of 1200rpm, encapsulation efficiency of 5-Fu nanoparticles was 55.4±1.10% and loading capacity was 4.22±0.14%; gastric cancer cells were significantly inhibited by 5-Fu nanoparticles in a time and concentration dependent manner, and compared to 5-Fu with slower drug release, in a certain concentration range, inhibition with 5-Fu nanoparticles was stronger. 5-Fu nanoparticles were absorbed by the cells in line with the concentration. CONCLUSIONS: 5-Fu nanoparticles can inhibit growth of gastric cancer cells in vitro to a greater extent than with 5-Fu with good adsorption characteristics, supporting feasibility as a carrier.


Subject(s)
Antimetabolites, Antineoplastic/administration & dosage , Drug Carriers , Drug Delivery Systems , Fluorouracil/administration & dosage , Nanoparticles/administration & dosage , Stomach Neoplasms/drug therapy , Stomach Neoplasms/metabolism , Antimetabolites, Antineoplastic/pharmacology , Apoptosis/drug effects , Cell Proliferation/drug effects , Flow Cytometry , Fluorouracil/pharmacology , Humans , Tumor Cells, Cultured
16.
Int J Neurosci ; 124(9): 642-51, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24325389

ABSTRACT

BACKGROUND: The endothelial nitric oxide synthase (eNOS) T-786C polymorphism has been implicated in a number of studies investigating ischemic stroke (IS), yet previously published studies showed inconsistent results that recent meta-analyses have not resolved. METHODS: In the comprehensive meta-analysis of 12 association studies involving 2836 IS cases and 3354 control subjects, we used a more stringent inclusion method and summarized data on the association of eNOS T-786C polymorphism and IS susceptibility. RESULTS: We found a significantly lowered IS risk under the CC vs. TT genetic model (odds ratio, OR = 0.53, 95% confidence interval, CI = 0.29-0.98, p = 0.160, I(2) = 45.5%) by random effects model in Caucasians and under the allele model C vs. T (OR = 0.42, 95% CI = 0.21-0.87) by fixed effects model in African-Americans. In addition, a significant increased risk of IS was observed in Asians (C vs. T: OR = 1.14, 95% CI = 1.02-1.28, p = 0.990, I(2) = 0.0%) by fixed effects model. Stratified analysis by mean age also showed that the allele C carriers, compared with the allele T allele carriers, had higher risk of suffering IS (OR = 1.16, 95% CI = 1.03-1.31) in the population of 60-65 years without heterogeneity. CONCLUSIONS: The combined results suggest that eNOS T-786C polymorphism may be associated with IS susceptibility among the population between 60 and 65 years in particular.


Subject(s)
Genetic Predisposition to Disease/genetics , Nitric Oxide Synthase Type III/genetics , Polymorphism, Genetic/genetics , Stroke/genetics , Genetic Association Studies , Humans
17.
J Headache Pain ; 14: 27, 2013 Mar 21.
Article in English | MEDLINE | ID: mdl-23574884

ABSTRACT

BACKGROUND: The clinical profile of cluster headache in Chinese patients have not been fully studied. METHODS: The classification and clinical features of 120 consecutive patients with cluster headache (105 males, 15 females; mean age, 34.9 ± 10.5 years) visiting at International Headache Center from May 2010 to August 2012 were analyzed. RESULTS: Patients came from 16 different regions of China. Mean age at onset of cluster headache was 26.7 ± 10.9 years. Only 13 patients (10.8%) had previously been diagnosed with cluster headache. Mean time to diagnosis from first symptoms was 8.2 ± 7.1 years (range, 0-35 years). Chronic cluster headache was observed in only 9 patients (7.5%). The most commonly reported location of cluster headache was temporal region (75.0%), followed by retro-orbital region (68.3%), forehead (32.5%), vertex (32.5%) and occipital (22.5%). Lacrimation was the most consistently reported autonomic feature (72.5%). During acute attacks, 60.0% of patients experienced nausea, and 41.7% experienced photophobia and 40.8% experienced phonophobia. In addition, 38.3% reported restless behavior and 45.8% reported that physical activity exacerbated the pain. None of patients experienced visual or other kinds of aura symptoms before cluster attacks. We found that 38.3% of patients had <1 cluster period and 35.8% for 1-2 cluster periods per year with these periods occurring less frequently during the summer than during other seasons. Cluster duration was 1-2 months in 32.5% of patients. During cluster periods, 73.3% of patients had 1-2 attacks per day, and 39.2% experienced cluster attacks ranging in duration from 1 h to less than 2 h. The duration of attacks were 1.5 (1-2.25) hours for males and 1.5 (1-3) for females respectively. The World Health Organization quality of life-8 questionnaire showed that cluster headache reduced life quality. CONCLUSIONS: Compared to Western patients, Chinese patients showed a relatively low prevalence of chronic cluster headaches, pain sites mainly focused on areas distributed by the first division of the trigeminal nerve, a low frequency of restlessness and absent aura. These clinical features may be more common in Eastern populations, including mainland Chinese, Japanese and Taiwanese patients, than in Western patients.


Subject(s)
Cluster Headache/epidemiology , Cluster Headache/physiopathology , Adolescent , Adult , Age of Onset , Child , Child, Preschool , China/epidemiology , Cluster Headache/classification , Female , Humans , Infant , Infant, Newborn , Male , Prevalence , Young Adult
18.
Lipids Health Dis ; 12: 11, 2013 Feb 06.
Article in English | MEDLINE | ID: mdl-23388073

ABSTRACT

BACKGROUND: Peroxisome proliferator activated receptor alpha (PPARα) ameliorates ethanol induced hepatic steatohepatitis. However, its role in alcoholic liver fibrosis has not been fully clarified. The aim of this study was to elucidate the effect and the molecular basis of PPARα in ethanol induced liver fibrosis in mice. METHODS: C57BL/6J mice were fed with 4% ethanol-containing Lieber-DeCarli liquid diet for eight weeks, and intraperitoneal injected with 5% carbon tetrachloride (CCl4) for the last four weeks to induce alcoholic liver fibrosis. PPARα agonist WY14643 was administered to mice during the last couple of weeks. The effects of PPARα induction on liver histology, activation of hepatic stellate cells (HSCs), as well as hepatic expression of inflammatory and fibrogenic factors were assessed. RESULTS: The ethanol plus CCl4 treated mice exhibited progressive liver injury including piecemeal necrosis of hepatocytes, severe inflammatory cells infiltration and bridging fibrosis. This was accompanied by down-regulated hepatic expression of PPARα and the protective cytokines adiponectin, heme oxygenase-1 and interleukin-10. Additionally, up-regulation of the proinflammatory cytokine tumor necrosis factor-alpha, as well as the profibrogenic genes osteopontin, transforming growth factor-beta 1, visfatin, phosphatidylinositol 3-kinase, matrix metalloproteinase-2 (MMP-2) and MMP-9 was observed. WY14643 treatment restored expression of cytokines altered by ethanol plus CCl4 treatment and concomitantly ameliorated the liver injury. CONCLUSIONS: The present study provides evidence for the protective role of PPARα induction in ameliorating ethanol mediated fibrosis through mediation of inflammatory and fibrogenic factors.


Subject(s)
Anticholesteremic Agents/pharmacology , Hepatic Stellate Cells/drug effects , Hepatocytes/drug effects , Liver Cirrhosis/drug therapy , PPAR alpha/genetics , Pyrimidines/pharmacology , Adiponectin/genetics , Adiponectin/metabolism , Animals , Carbon Tetrachloride , Cytokines/genetics , Cytokines/metabolism , Ethanol , Gene Expression Regulation/drug effects , Heme Oxygenase-1/genetics , Heme Oxygenase-1/metabolism , Hepatic Stellate Cells/metabolism , Hepatic Stellate Cells/pathology , Hepatocytes/metabolism , Hepatocytes/pathology , Interleukin-10/genetics , Interleukin-10/metabolism , Liver/drug effects , Liver/metabolism , Liver/pathology , Liver Cirrhosis/chemically induced , Liver Cirrhosis/metabolism , Liver Cirrhosis/pathology , Male , Matrix Metalloproteinases/genetics , Matrix Metalloproteinases/metabolism , Mice , Mice, Inbred C57BL , Nicotinamide Phosphoribosyltransferase/genetics , Nicotinamide Phosphoribosyltransferase/metabolism , Osteopontin/genetics , Osteopontin/metabolism , PPAR alpha/metabolism , Signal Transduction/drug effects , Transforming Growth Factor beta1/genetics , Transforming Growth Factor beta1/metabolism , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
19.
PLoS One ; 7(12): e50898, 2012.
Article in English | MEDLINE | ID: mdl-23239993

ABSTRACT

BACKGROUND: China has the huge map and the largest population in the world. Previous studies on the prevalence and classification of headaches were conducted based on the general population, however, similar studies among the Chinese outpatient population are scarce. This study aimed to analyze the characteristics of 1843 headache patients enrolled in a North China headache clinic of the General Hospital for Chinese People's Liberation Army from October 2011 to May 2012, with the International Classification of Headache Disorders, 2nd Edition (ICHD-II). METHODS AND RESULTS: Personal interviews were carried out and a detailed questionnaire was used to collect medical records including age, sex and headache characteristics. Patients came from 28 regions of China with the median age of 40.9 (9-80) years and the female/male ratio of 1.67/1. The primary headaches (78.4%) were classified as the following: migraine (39.1%), tension-type headache (32.5%), trigeminal autonomic cephalalgias (5.3%) and other primary headache (1.5%). Among the rest patients, 12.9% were secondary headaches, 5.9% were cranial neuralgias and 2.5% were unspecified or not elsewhere classified. Fourteen point nine percent (275/1843) were given an additional diagnosis of chronic daily headache, including medication-overuse headache (MOH, 49.5%), chronic tension-type headache (CTTH, 32.7%) and chronic migraine (CM, 13.5%). The visual analogue scale (VAS) score of TTH with MOH was significantly higher than that of CTTH (6.8±2.0 vs 5.6±2.0, P<0.001). The similar result was also observed in VAS score between migraine with MOH and CM (8.0±1.5 vs 7.0±1.5, P = 0.004). The peak age at onset of TTH for male and female were both in the 3(rd) decade of life. However, the age distribution at onset of migraine shows an obvious sex difference, i.e. the 2(nd) decade for females and the 1(st) decade for males. CONCLUSIONS/SIGNIFICANCE: This study revealed the characteristics of the headache clinic outpatients in a tertiary hospital of North China that migraine is the most common diagnosis. Furthermore, most headaches in this patient population can be classified using ICHD-II criteria.


Subject(s)
Headache , Surveys and Questionnaires , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Child , China , Female , Headache/classification , Headache/diagnosis , Headache/epidemiology , Headache/physiopathology , Humans , Male , Middle Aged , Sex Factors
20.
Chin J Integr Med ; 13(2): 98-102, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17609906

ABSTRACT

OBJECTIVE: To observe the clinical effect of Astragalus Injection (, AI) and its immuno-regulatory action in treating chronic aplastic anemia (CAA). METHODS: Sixty patients with CAA were randomly assigned to two groups equally, both were treated with Stanozolol three times a day, 2 mg each time through oral intake, but AI was given additionally to the patients in the treated group once a day via intravenous dripping. All were treated for 15 days as one therapeutic course and the whole medication lasted for more than 4 months totally, with follow-up adopted. The clinical efficacy was estimated and the changes of T-lymphocyte subsets in peripheral blood as well as the serum levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-2 (IL-2) were observed. RESULTS: The total effective rate in the treated group was 83.3% (25/30), which was higher than that in the control group 66.7% (20/30), showing significant difference between them (P<0.05). Levels of hemoglobin, WBC, reticular cell and platelet were elevated in both groups after treatment, but the improvement was significantly better in the treated group than that in the control group with respect to the former three indexes (P<0.05). The level of CD4(+) increased and that of CD8(+) decreased significantly after treatment in the treated group (P<0.05), which showed significant difference as compared with those in the control group (P<0.05). Levels of serum TNF-alpha and IL-2 lowered after treatment in both groups, but significance only showed in the treated group (P<0.05). The degree of proliferation in bone marrow got raised significantly and the percentage of non-hemopoietic cells reduced significantly in the treated group after treatment, also showing significant difference to those in the control group (P<0.05). CONCLUSION: AI could promote the recovery of hemopoietic function, which might be through improving T-lymphocyte subsets and reducing the release of negative regulatory factors such as TNF-alpha and IL-2 to alleviate the inhibition on hemopoietic function.


Subject(s)
Anemia, Aplastic/drug therapy , Astragalus Plant , Drugs, Chinese Herbal/therapeutic use , Anemia, Aplastic/blood , Anemia, Aplastic/immunology , Bone Marrow/drug effects , Chronic Disease , Follow-Up Studies , Humans , Injections , Interleukin-2/blood , Tumor Necrosis Factor-alpha/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...